Spark Therapeutics Stock
-
Your prediction
Pros and Cons of Spark Therapeutics in the next few years
Pros
Cons
Performance of Spark Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | 1.010% | 4.211% | 11.864% | 107.330% | 19.277% | 182.857% | 63.704% |
| United Therapeutics | -1.160% | -3.219% | 3.308% | 88.659% | 13.293% | 134.886% | 176.629% |
| Ionis Pharmaceuticals Inc. | -1.860% | -2.798% | -0.509% | 139.159% | -7.975% | 91.195% | 77.117% |
News
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December

